Your browser doesn't support javascript.
loading
Sensitive and modular amplicon sequencing of Plasmodium falciparum diversity and resistance for research and public health.
Aranda-Díaz, Andrés; Vickers, Eric Neubauer; Murie, Kathryn; Palmer, Brian; Hathaway, Nicholas; Gerlovina, Inna; Boene, Simone; Garcia-Ulloa, Manuel; Cisteró, Pau; Katairo, Thomas; Semakuba, Francis Ddumba; Nsengimaana, Bienvenu; Gwarinda, Hazel; García-Fernández, Carla; Da Silva, Clemente; Datta, Debayan; Kiyaga, Shahiid; Wiringilimaana, Innocent; Fekele, Sindew Mekasha; Parr, Jonathan B; Conrad, Melissa; Raman, Jaishree; Tukwasibwe, Stephen; Ssewanyana, Isaac; Rovira-Vallbona, Eduard; Tato, Cristina M; Briggs, Jessica; Mayor, Alfredo; Greenhouse, Bryan.
Afiliação
  • Aranda-Díaz A; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Vickers EN; Chan Zuckerberg Biohub, San Francisco, California, USA.
  • Murie K; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Palmer B; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Hathaway N; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Gerlovina I; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Boene S; EPPIcenter Research Program, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Garcia-Ulloa M; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
  • Cisteró P; ISGlobal, Barcelona, Spain.
  • Katairo T; ISGlobal, Barcelona, Spain.
  • Semakuba FD; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Nsengimaana B; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Gwarinda H; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • García-Fernández C; Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR), Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Da Silva C; ISGlobal, Barcelona, Spain.
  • Datta D; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
  • Kiyaga S; ISGlobal, Barcelona, Spain.
  • Wiringilimaana I; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Fekele SM; Department of Immunology and Molecular Biology, College of Health Sciences, Makerere University, Kampala, Uganda.
  • Parr JB; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Conrad M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Raman J; Department of Environment and Genetics, La Trobe University, Melbourne, Australia.
  • Tukwasibwe S; Division of Infectious Diseases, University of North Carolina at Chapel Hill, North Carolina, USA.
  • Ssewanyana I; Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, California, USA.
  • Rovira-Vallbona E; Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research (ARMMOR), Centre of Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Tato CM; Wits Research Institute for Malaria, University of Witwatersrand, Johannesburg, South Africa.
  • Briggs J; University of Pretoria Institute for Sustainable Malaria Control (UPISMC), University of Pretoria, Pretoria, South Africa.
  • Mayor A; Infectious Diseases Research Collaboration, Kampala, Uganda.
  • Greenhouse B; Infectious Diseases Research Collaboration, Kampala, Uganda.
bioRxiv ; 2024 Aug 25.
Article em En | MEDLINE | ID: mdl-39229023
ABSTRACT
Targeted amplicon sequencing is a powerful and efficient tool to interrogate the P. falciparum genome and generate actionable data from infections to complement traditional malaria epidemiology. For maximum impact, genomic tools should be multi-purpose, robust, sensitive and reproducible. We developed, characterized, and implemented MAD4HatTeR, an amplicon sequencing panel based on Multiplex Amplicons for Drug, Diagnostic, Diversity, and Differentiation Haplotypes using Targeted Resequencing, along with a bioinformatic pipeline for data analysis. MAD4HatTeR targets 165 highly diverse loci, focusing on multiallelic microhaplotypes; key markers for drug and diagnostic resistance, including duplications and deletions; and csp and potential vaccine targets. In addition, it can detect non-falciparum Plasmodium species. We used laboratory control and field sample data to demonstrate the high sensitivity and robustness of the panel. The successful implementation of this method in five laboratories, including three in malaria-endemic African countries, showcases its feasibility in generating reproducible data across laboratories. Finally, we introduce an analytical approach to detect gene duplications and deletions from amplicon sequencing data. MAD4HatTeR is thus a powerful research tool and a robust resource for malaria public health surveillance and control.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article